Visionix USA

Visionix USA Our mission is to improve access to a comprehensive portfolio of advanced visual health solutions that enhance the patient experience.

We deeply believe that thorough research and understanding of the existing challenges and innovation through technology will be key to unlocking the potential of eye care professionals to best serve their patients. Visionix USA, as part of the global Visionix organization, serves as the exclusive sales, service, and training provider in the United States for Optovue OCT/OCT-A devices, multimodal V

isionix screening and refraction systems, and Briot and Weco lens finishing equipment. We support eye care professionals with innovative technologies, including the Optovue Solix OCT-A and a wide range of multimodal diagnostic and management solutions for ocular disease. In partnership with 20/20NOW, our Ocular Telehealth Program provides additional flexibility to grow your practice while ensuring the doctor remains in control of the full patient care experience. Backed by more than a century of innovation, along with robust support and clinical education, Visionix USA is uniquely positioned to help you unlock your full potential.

06/16/2026

Meibography: After the acquisition, how do you interpret the results?

With Optovue Solix, Meibomian gland imaging is fast and simple… but the key challenge remains the analysis.

To guide interpretation, the Meibomian gland atrophy classification proposed by Pr. Dighiero provides a structured reading:

Stage 1: Mild involvement
Stage 2: Moderate atrophy
Stage 3: Severe atrophy

This approach facilitates:
✔️ Standardized assessment
✔️ Improved long-term monitoring
✔️ Clinical decision support

Combined with Solix’s superior image quality, it allows for the full integration of meibography into daily practice and dry eye management.

Thank you to Professor Pablo Dighiero for providing these clinical images.

At Visionix, we develop solutions that go beyond just data acquisition to support practitioners all the way through interpretation.

Learn more about Optovue Solix at: https://eu1.hubs.ly/H0vbY0_0

The Heat Is Back and So Are We!  Celebrating Year Three of Our Summer Recertification Sale—Back and Better Than Ever. We...
06/15/2026

The Heat Is Back and So Are We!

Celebrating Year Three of Our Summer Recertification Sale—Back and Better Than Ever. We’re marking three years of unbeatable value and turning up the heat with extra savings.

Refresh your practice with top-quality, fully recertified OCTs, refraction equipment, edgers, and more—now up to 50% off, plus a FREE extra year of warranty on certain devices!

Upgrade your technology, elevate patient care, and do it all without stretching your budget. But don’t wait, these hot deals won’t last forever.

06/11/2026

As we refine our approach to glaucoma, a fundamental question remains: Is OCT-A simply a diagnostic "snapshot," or is it the key to identifying your most vulnerable patients before functional loss occurs?

In this part of our series featuring Dr. Sayeh Pourjavan, our global counterparts dive into the strategic utility of vascular imaging: "Do you see OCT-A primarily as a diagnostic tool or as a method for risk assessment and stratification?“

See her full answer in the video! 📽️

Learn more about Optovue Solix at: https://eu1.hubs.ly/H0v95Cr0

Visionix is headed to Phoenix! 🌵 Join us at the American Optometric Association meeting from June 17–20 and stop by Boot...
06/09/2026

Visionix is headed to Phoenix! 🌵

Join us at the American Optometric Association meeting from June 17–20 and stop by Booth #1333 to explore our latest innovations in OCT, refraction, and finishing equipment.

Discover how we’re helping practices enhance efficiency, elevate patient care, and stay ahead with smarter technology.

We look forward to seeing you there!

06/04/2026

Did you know that the Optovue Solix is one of the few OCTs capable of performing meibography?

Thanks to its ultra-high-resolution multimodal imaging technology, everything is done on a single platform: no extra equipment is needed to examine the Meibomian glands.

👉 Fewer devices
👉 Saves space in the practice
👉 Saves time during consultations
👉 Optimized investment

The Solix expands the scope of examinations—from the retina to the ocular surface—for more comprehensive and efficient patient care, particularly for dry eye management.

At Visionix, we design solutions that simplify your practice while maximizing clinical value.

Learn more about the Solix https://eu1.hubs.ly/H0v94W_0

06/02/2026

Do you also hold your breath every time you hit 'start' on a high-end hydrophobic lens, fearing it might twist?

Know that there is a way to end the 'slippage stress' for good: activating a dedicated advanced edging cycle (like TMS).

By automatically adapting the edging cycle to the lens material and coating, you maintain perfect control and keep the axis exactly where you set it.

✔ Better axis stability
✔ Less slippage
✔ Higher first-fit rate

Learn more at: https://eu1.hubs.ly/H0vbZ210

🚚 Visionix is hitting the road! We’re bringing innovation, efficiency, and smarter workflows to a city near you. Catch u...
06/01/2026

🚚 Visionix is hitting the road!

We’re bringing innovation, efficiency, and smarter workflows to a city near you.

Catch us this month at:
☑️ Vision Trends Annual Meeting
☑️ Utah Optometric Association (UOA) Annual Congress
☑️ Optometric Association of Louisiana (OAL)
☑️ Texas State Optical (TSO)
☑️ Native American Optometry Conference
☑️ Mississippi Optometric Association (MOA)
☑️ Optometric Education Consultants (OEC) – Florida

Stop by to see how Visionix technology can help elevate your practice and enhance patient care.

📍 Check the list - we might be closer than you think!

05/29/2026

In glaucoma management, precision is everything. While OCT-A provides a window into the microvasculature, it also introduces a unique set of challenges: variability and artifacts. Our global counterparts continued their conversation with Dr. Sayeh Pourjavan to address one of the most critical aspects of image interpretation: "What are the most common OCT-A artifacts or sources of variability that clinicians should be aware of?"

See her full answer in the video! 📽️

Learn more about Optovue Solix at
https://eu1.hubs.ly/H0vHdCQ0

For informational purposes only, medical practices and recommendations may vary by region. The authors disclaim liability for any outcomes from use of this information; use your own judgment.

Today marks an exciting milestone for iCare and Visionix. Together, we are joining forces to create a stronger and more ...
05/28/2026

Today marks an exciting milestone for iCare and Visionix.

Together, we are joining forces to create a stronger and more comprehensive global eye care solutions provider, combining highly complementary expertise across diagnostics, imaging, refraction, OCT, and workflow technologies.

By bringing together our technologies, innovation capabilities, and global teams, we are strengthening our ability to support eye care professionals across the full patient journey with connected and integrated solutions.

Most importantly, our commitment to customers, partners, and innovation remains stronger than ever.

Together, we are building the future of connected eye care.

05/26/2026

Do you find it hard to stand out when everyone in town carries the same collections?

Know that there is a way to offer something truly exclusive: integrated shape customization. Adjust heights, widths, or curves on the fly to perfectly match your client's needs without changing the frame they love.

✔ Repair demo lenses
✔ Create unique shapes
✔ Offer customized designs

https://eu1.hubs.ly/H0v1FMJ0

Address

160 North Eisenhower Lane
Lombard, IL
60148

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 9am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18007291959

Alerts

Be the first to know and let us send you an email when Visionix USA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Visionix USA:

Share